- >=99.1 HPLCHPLC / MSIn stock
Research compound
Tesamorelin
Tesamorelin is a synthetic analog of human GHRH (hGHRH 1-44 amide) specified with a trans-3-hexenoic acid group conjugated to the N-terminal tyrosine. This hexenoyl modification is documented to confer dipeptidyl peptidase IV resistance and extend pharmacokinetic half-life relative to native GHRH in biochemical models. Full agonist activity at the GHRH receptor is retained, with characterized Gs-protein/cAMP signal transduction in pituitary somatotroph cultures. The modification provides a defined parameter for studying GHRH receptor kinetics independently of proteolytic stability. For laboratory research use only.
Specification
- CAS
- 218949-48-9
- Molecular weight
- 5135.89 g/mol
- Formula
- C221H366N68O66S
- Purity
- >=99.1 HPLC
- Storage
- -20 °C, lyophilized
Size
Research notes
What is Tesamorelin?
Tesamorelin is a synthetic research compound studied in laboratory settings. It has molecular formula C221H366N68O66S, a molecular weight of 5135.89 g/mol, CAS 218949-48-9. It is intended for in vitro research use only and is not for human or animal use.
What purity is Valitec Peptides's Tesamorelin?
Valitec Peptides supplies Tesamorelin at >=99.1% purity, verified by third-party HPLC analysis. A certificate of analysis is available on request.
How is Tesamorelin supplied?
Tesamorelin is supplied as a lyophilized powder in sealed research-grade vials, stored -20 °C, lyophilized, intended for in vitro and laboratory research use only.
For laboratory research use only. Not for human or veterinary use, and not for diagnostic or therapeutic use.